Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib - Poll - MDSpire

Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib

  • By

  • Francesca Palandri

  • Elena M. Elli

  • Giuseppe Auteri

  • Massimiliano Bonifacio

  • Giulia Benevolo

  • Florian H. Heidel

  • Simona Paglia

  • Malgorzata M. Trawinska

  • Costanza Bosi

  • Elena Rossi

  • Mario Tiribelli

  • Alessia Tieghi

  • Alessandra Iurlo

  • Nicola Polverelli

  • Giovanni Caocci

  • Gianni Binotto

  • Francesco Cavazzini

  • Eloise Beggiato

  • Daniela Cilloni

  • Caterina Tatarelli

  • Francesco Mendicino

  • Maurizio Miglino

  • Monica Bocchia

  • Monica Crugnola

  • Camilla Mazzoni

  • Andrea D. Romagnoli

  • Giovanni Rindone

  • Sara Ceglie

  • Alessandra D’Addio

  • Eleonora Santoni

  • Daniele Cattaneo

  • Daniela Bartoletti

  • Roberto M. Lemoli

  • Mauro Krampera

  • Antonio Cuneo

  • Gianpietro C. Semenzato

  • Roberto Latagliata

  • Elisabetta Abruzzese

  • Nicola Vianelli

  • Michele Cavo

  • Alessandro Andriani

  • Valerio De Stefano

  • Giuseppe A. Palumbo

  • Massimo Breccia

  • May 3, 2023

  • 0 min

Share

Original Source(s)

Related Content